Trump's wish for lower interest rates has effectively vanished, largely due to two of his own decisions.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]
Cathie Wood, chief of Ark Investment Management, likes to double down on her favorite tech stocks when the prices are falling, hoping for a bargain. That’s what Wood just did, adding shares of Coinbase after weeks of tumbling. In 2025, Wood's flagship Ark Innovation ETF gained 35.49%, far outpacing ...
Few congressional portfolios attract as much scrutiny as Nancy Pelosi's. Her husband, Paul Pelosi, who executes the family's trades, has previously disclosed bets on Microsoft and Alphabet that outpaced the S&P 500. His latest moves may draw even more attention. Investing.com ...
Micron (MU) stock closed the June 25 trading session up 15.81% at $1,213.56. The stock soared following the release of the third-quarter (Q3) fiscal year 2026 (FY26) earnings report on June 24. The stock is up 313.14% year-to-date, at the time of writing, Friday afternoon, June 26. Meanwhile, the ...
With the recent 130th anniversary of the Dow, let’s take a closer look at why this old and narrow index still commands so much attention. Until the S&P 500 began circulating in the 1950s – and then NASDAQ in the 1970s – the Dow was the most widely quoted measure of the market’s health each day, ...
SpaceX stock is now down roughly 24% from its high. What comes next?
Barclays has increased its year-end target for the S&P 500 to 7,800 from 7,650 and introduced a 2027 target of 8,800, reflecting a more optimistic earnings outlook even as investors face a more challenging market environment in the months ahead. The bank said the outlook for equities remains mixed, with several competing forces influencing sentiment.
Tech stocks had another subpar day, as worries about AI spending—and its inflationary impact on consumers—mount.
An annual report finds donations to nonprofits rose by 3% in inflation-adjusted dollars to $617.2 billion in 2025
The S&P 500 and Nasdaq composite fell in every day of a calendar week for the first time since April 2024, losing about 2% and 4.6%, respectively. “I just don’t think it’s a time as an investor that you should be focused on swinging for the fences,” said Jim Baird, chief investment officer at Plante Moran Financial Advisors. The declines continued this past week, which began with a tech selloff that ripped through chip makers from Seoul to Santa Clara, Calif. Micron’s upbeat outlook after Wednesday’s close looked set to spark a rebound, but momentum faded quickly, especially after Apple and Microsoft announced they would increase prices for MacBooks and Xbox gaming consoles, respectively.
Most of the U.S. stock market rose after oil prices eased back to where they were before the war with Iran, but drops for AI stocks kept the market in check. The Dow Jones Industrial Average fell 0.1%, and the Nasdaq composite lost 0.2%. The Nasdaq composite fell 60.99 points, or 0.2%, to 25,297.62.

Yahoo Finance's Jared Blikre takes a closer look at some of Friday's trending tickers and stories, including Moderna (MRNA), Netflix (NFLX), and ON Semiconductor (ON).
QCR Holdings has had an impressive run over the past six months as its shares have beaten the S&P 500 by 7.8%. The stock now trades at $96.64, marking a 14% gain. This run-up might have investors contemplating their next move.
June 26 (Reuters) - Wall Street's main indexes fell on Friday, as chipmakers came under renewed selling pressure after a stellar run this quarter, with investors questioning high valuations and the
June 26 (Reuters) - Futures tied to the tech-heavy Nasdaq led Wall Street losses on Friday, as chip stocks came under renewed pressure after a sharp rally in the previous session, while some megacap
Cerebras soared 68% on its first day of trading.
Buffett has a clear opinion when it comes to IPOs.

<body><p>STORY: U.S. stocks ended mixed on Thursday, with the Dow ticking up more than a tenth of a percent, while the S&P 500 closed flat and the Nasdaq dropped nearly half a percent.</p><p>Technology shares reversed early gains to move lower, as investors worried about hyperscaler spending on AI and who foots the bill.</p><p>:: Micron</p><p>Those fears outweighed upbeat signals on AI demand from Micron, which gained nearly 16%, while shares of Sandisk soared 22%.</p><p>Brian Mulberry, chief market strategist at Zacks Investment Management, notes that it's memory chip makers that are now leading the charge. </p><p>"What's different about Micron, SanDisk, Western Digital, those types of names that are doing so well is that they're memory chips. And you have to have memory, specifically DRAM or H-band memory, if you're going to have enough computing power to do all the computations. That is nothing if you don't have memory to transfer it from one place to another. So one of the reasons that these stocks have done so well and the growth at Micron is so solid is because a recent redesign in the server technology means we go from eight memory chips per server to 96. That's 12 times growth in demand for this one simple component."</p><p>The surging prices of memory and storage chips prompted Apple on Thursday to hike prices for its iPads and MacBooks. That weighed on the stock, sending it down more than 6%. Shares of Nvidia, Microsoft and Alphabet also dropped.</p><p>:: Archive</p><p>Among other movers, shares of Bio-Techne jumped after Merck agreed to acquire the biotech firm for $73 per share in cash, representing a total enterprise value of about $11.3 billion.</p><p>:: Archive</p><p>Meanwhile, U.S. Department of Commerce data on Thursday showed the annual inflation rate through May rose above 4% for the first time in three years, but oil prices this week fell to below pre-war levels.</p></body>
On June 25, 2026, investors tracked deal progress as Bio-Techne shares responded to the proposed buyout terms.